These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1417408)

  • 1. [Proarrhythmic effects of antiarrhythmic drugs].
    Fauchier JP; Babuty D; Fauchier L; Rouesnel P; Cosnay P
    Arch Mal Coeur Vaiss; 1992 Jun; 85(6):891-7. PubMed ID: 1417408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pro-arrhythmic effects of anti-arrhythmia agents].
    Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiac side effects of anti-arrhythmia agents].
    Seipel L
    Z Kardiol; 1988 Feb; 77(2):77-88. PubMed ID: 3284219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
    Gülker H; Thale J
    Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-arrhythmic drug prevention of sudden cardiac death--the status after the CAST study].
    Seipel L; Kühlkamp V
    Z Gesamte Inn Med; 1992 May; 47(5):189-94. PubMed ID: 1615728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse cardiovascular effects of anti-arrhythmia drugs. Part I: Proarrhythmic effects.
    Libersa C; Caron J; Guedon-Moreau L; Adamantidis M; Nisse C
    Therapie; 1992; 47(3):193-8. PubMed ID: 1295120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Torsades de pointe" and reentry induced by anti-arrhythmia agents].
    Brochier M; Fauchier JP
    Arch Mal Coeur Vaiss; 1978 Apr; 71(4):477-88. PubMed ID: 78692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possibilities and limitations of treatment for arrhythmia].
    Lüderitz B
    Z Gesamte Inn Med; 1991 Aug; 46(12):425-30. PubMed ID: 1950023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and toxicity of antiarrhythmic drug therapy: benefit versus risk.
    Podrid PJ
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S65-73. PubMed ID: 1723122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dangerous arrhythmias].
    Gertsch M; Fuhrer J
    Schweiz Med Wochenschr; 1993 May; 123(17):833-43. PubMed ID: 8497770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug prevention of recurrence in paroxysmal and chronic atrial fibrillation].
    Hindricks G; Kottkamp H; Willems S; Haverkamp W; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():87-96. PubMed ID: 7846950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of arrhythmias in chronic cardiac insufficiency].
    Motté G; Slama M; Drieu L
    Arch Mal Coeur Vaiss; 1990 Nov; 83(13):1963-6. PubMed ID: 1980188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pro-arrhythmic effects of antiarrhythmic drugs in patients with ischemic heart disease].
    Trusz-Gluza M; Smieja-Jaroczyńska B; Szymkowiak-Rzechorzek E; Buszman P; Dabrowski A; Kuśnierz B; Lada W; Luczak D; Mroczek-Czernecka D; Piotrowicz R
    Kardiol Pol; 1990; 33(5):328-34. PubMed ID: 2074629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic therapy for ventricular arrhythmias.
    Zimmermann M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S59-64. PubMed ID: 1723121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety of new anti-arrhythmic drugs].
    Touboul P
    Arch Mal Coeur Vaiss; 2005 Apr; 98(4):313-6. PubMed ID: 15881847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arrhythmogenic effects of anti-arrhythmia agents].
    Pfeiffer D; Rostock KJ; Rathgen K; Schirdewan A; Kleiner HJ
    Z Gesamte Inn Med; 1987 Jul; 42(14):390-4. PubMed ID: 3673134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arrhythmogenic effect of ajmaline on the atrial level].
    Brembilla-Perrot B; al Ammar A; Terrier de la Chaise A; Cherrier F; Pernot C
    Arch Mal Coeur Vaiss; 1989 Dec; 82(12):1983-90. PubMed ID: 2515824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["Arrhythmica" or: history, extent and practical consequences of pro-arrhythmia effects].
    Gertsch M
    Schweiz Med Wochenschr; 1996 Apr; 126(14):566-75. PubMed ID: 8668970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.